Navigation Links
Informed Medical Communications Appoints New Chief Financial Officer
Date:5/27/2008

EDISON, N.J., May 27 /PRNewswire/ -- Informed Medical Communications (IMC), a leading provider of peer-to-peer medical forums for the bio-pharmaceutical industry, today announced the appointment of Bert Marchio to the position of Executive Vice President/Chief Financial Officer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080512/NYM105LOGO )

Marchio brings to IMC over 20 years of experience in senior financial leadership positions in both the public and private sectors, with the last 15 years spent in the pharmaceutical industry. Most recently, he served as Vice President, Treasurer of MedPointe where he helped lead the financial turnaround and eventual sale of the company. During his tenure, the value of MedPointe shares doubled and the company saw a dramatic improvement in cash flow. Prior to this, Marchio helped finance the domestic and international growth of Alpharma from under $300MM in sales (1992) to approximately $1.3B (2005) while building treasury, tax, risk management and benefit finance systems as their Vice President, Treasurer. Marchio holds a BA in Economics from Muhlenberg College, an MBA in Professional Accounting from Rutgers Graduate School of Business and a Post-MBA Certificate in Taxation from Bernard Baruch College.

"Bert has tremendous experience in the financial and pharmaceutical realms, which will be invaluable to us as we continue to grow the IMC business," said Steve Budd, CEO of IMC. "We are equally excited by the fact that the tremendous potential of IMC has attracted someone of Bert's caliber in this critical role."

About Informed Medical Communications

Informed Medical Communications (http://www.informedmedical.com), headquartered in Edison, NJ, is an interactive medical marketing group of companies providing services to the biopharmaceutical industry
'/>"/>

SOURCE Informed Medical Communications
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Informed Medical Communications Appoints Charles T. Saldarini to Board of Directors
2. InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
3. Informed Medical Communications Hires New Vice President of Marketing
4. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
5. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
6. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
7. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
8. BioMS Medical announces its intention to renew a normal course issuer bid
9. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
10. ATS Medical Expands Open Pivot Heart Valve Offerings
11. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... March 2, 2015  Pfenex Inc. (NYSE MKT: ... development of biosimilar therapeutics, today announced that it ... Healthcare Conference in Miami, FL at the Loews Miami Beach ... officer of Pfenex, will provide an overview of ... 12th at 9:00 am ET. A live audio webcast and ...
(Date:3/2/2015)... 2015 Editor Note: For more ... Moments ago, Analysts Review released new research updates ... (NASDAQ: SSH ), Synergetics USA ... ELOS ), Spectranetics (NASDAQ: SPNC ), and ... single unified platform for investors, to hear about what matters ...
(Date:3/2/2015)... SANTA BARBARA, Calif. , March 2, 2015 ... a biotechnology company developing therapies for autoimmune and ... Trademark Office (USPTO) has issued an important new ... immune system function through the targeting of CLIP. ... the targeted peptide technology underlying VG Life Sciences, ...
(Date:3/2/2015)... Global Stem Cells Group.com ... Shenzhen HANK Bioengineering Co., Ltd. and its Chinese-American ... establish a stem cells training course in the ... 2015. , Shenzhen HANK is a biotechnology company ... microbiologist and virologist, to integrate research, development, production, ...
Breaking Biology Technology:Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3
... Launch Interactive, Case-Based Website on Cardiovascular Disease for ... Whether it,s a common heart condition or a ... similar patient. That,s why the Society for Cardiovascular ... Inc. (EVF), an IC Sciences Company, today unveiled ...
... iZumi Bio, Inc., a biotechnology company focused on ... technology with the mission of creating new therapeutics ... cells, today announced the appointments of Berta Strulovici, ... Pathak, Ph.D., as vice president of Business Development. ...
... announced successful,completion of the single-day oral dosing part ... patients with its new anti-cancer drug AXL1717,an,insulin-like growth ... the closely related insulin receptor. The study is ... The results showed that a single-day,dosing of AXL1717 ...
Cached Biology Technology:New Website Connects Physicians to Solve Challenging Cases and Share Experiences 2New Website Connects Physicians to Solve Challenging Cases and Share Experiences 3New Website Connects Physicians to Solve Challenging Cases and Share Experiences 4iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development 2iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development 3Successful Phase I/II Clinical Trial Results From Cancer Patients Treated With Anti-Cancer Drug From Axelar AB 2
(Date:2/24/2015)... Feb. 24, 2015 This report analyzes the worldwide ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Middle East ... estimates and forecasts are provided for the period 2013 through ... markets. Market data and analytics are derived from primary and ...
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/10/2015)... 10, 2015  Alere Inc. (NYSE: ALR), a ... results for the quarter ended December 31, 2014. ... President of Alere said, "We made substantial progress ... the global leader in rapid diagnostics and delivering ... Health divestiture in early January enabled us to ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Cepheid to Webcast Upcoming Financial Presentations 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25
... MA.April 25th, 2012Aspera, Inc., creators of next-generation software ... speed, and BGI, the world,s largest genomics research ... have partnered to integrate and deploy the Aspera ... technology with "EasyGenomicsTM", BGI,s latest cloud-based Software as ...
... in state in 1970s; Zoo has monitored for beetle since ... Beetle Conservation; the U.S. Fish & Wildlife Service; the Missouri ... to 600 Zoo-bred American burying beetles for the first ... across the 4,040-acre Wah, Kon-Tah Prairie in Southwest Missouri. ...
... reported to increase risk of developing hepatocellular carcinomas (HCC), independent ... of Hepatology , a journal of the American Association ... 70-fold elevated risk of HCC in those with liver cancer ... hepatitis C (HCV). Liver cancer ranks sixth in ...
Cached Biology News:BGI and Aspera collaborate on high-speed data exchange to advance genome research 2First-ever release of endangered burying beetles in Missouri 2First-ever release of endangered burying beetles in Missouri 3First-ever release of endangered burying beetles in Missouri 4Family history of liver cancer increases risk of developing the disease 2
St. Louis encephalitis Immunogen: St. Louis encephalitis. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse Anti-Gemin2...
5-bromo-2'-deoxyuridine (BrdU) Cell Biology Cell Proliferation Bromodeoxyuridine (BrdU) and Related Products...
Rat CINC-2 alpha/beta Affinity Purified Polyclonal Ab...
Biology Products: